Motaz Qadan, MD, PhD, surgical director of the Mass General Brigham Cancer Institute at Massachusetts General Hospital since 2023, is a nationally recognized expert in hepatobiliary and pancreatic surgical oncology. Dr. Qadan leads one of the highest-volume programs in the country for complex liver and pancreas surgery, consistently achieving outcomes that meet the highest standards of quality and safety. In addition, he has served as section head of the Hepatobiliary/Liver Program at Mass General, where he is an integral member of the multidisciplinary team delivering coordinated, personalized care for patients with gastrointestinal cancers. His clinical expertise includes the surgical treatment of pancreatic cancer, liver tumors, bile duct cancer, and metastatic disease involving the liver.
Dr. Qadan earned both his undergraduate and medical degrees from the University of Edinburgh Medical School, one of Western Europe’s leading medical institutions. He completed his general surgery residency at Stanford University, where he was administrative chief resident, followed by a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as educational coordinator. Dr. Qadan is a fellow of the American College of Surgeons and a member of the Royal College of Surgeons of Edinburgh.
